Castle Biosciences, Inc.

Healthcare

NASDAQ:CSTL · NASDAQ Global Market

Market Cap $640.57M Beta 1.02 P/E (TTM) -47.3

$21.12 +0.20%

+$0.04 today

52W Low $14.59High $44.28

Vol 0.71M · Avg 0.37M

EPS (TTM) -$0.43Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+12.04%

Period High

$43.04

Period Low

$14.65

Latest

$21.12

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.54B

CareDx, Inc

NASDAQ:CDNA

$1.28B

AMN Healthcare Services, Inc.

NYSE:AMN

$1.20B

Personalis, Inc.

NASDAQ:PSNL

$887.60M

Geron Corporation

NASDAQ:GERN

$830.77M

Fulgent Genetics, Inc.

NASDAQ:FLGT

$512.49M

Evolent Health, Inc.

NYSE:EVH

$495.48M

Myriad Genetics, Inc.

NASDAQ:MYGN

$423.60M

Embecta Corp.

NASDAQ:EMBC

$184.05M

DarioHealth Corp.

NASDAQ:DRIO

$51.26M

What is the latest CSTL filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does CSTL have?

Intrinsic Alpha currently shows 20 recent filings for CSTL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.